Results 51 to 60 of about 18,379 (288)

Agammaglobulinemia with normal B-cell numbers in a patient lacking Bob1.

open access: yesJournal of Allergy and Clinical Immunology, 2021
CAPSULE SUMMARY Bob1 deficiency reduces B-cell responsiveness, impairs plasmablast formation and immunoglobulin secretion. Bob1 deficiency presents with increased susceptibility to respiratory infections and agammaglobulinemia despite normal B-cell ...
P. Kury   +18 more
semanticscholar   +1 more source

Subcutaneous IgG Replacement Therapy by Push in 32 Patients with Primary Immunodeficiency Diseases in Argentine [PDF]

open access: yes, 2014
Introduction: Regular replacement with immunoglobulin infusions is the mainstay of treatment in the majority of primary immunodeficiencies. Several studies showed that Subcutaneous Immunoglobulin (SCIG) has similar efficacy to Intravenous Immunoglobulin (
Bezrodnik, Liliana   +6 more
core   +1 more source

Novel BTK mutation in X-linked agammaglobulinemia: Report of a 17-year-old male.

open access: yesAllergologia et Immunopathologia, 2021
INTRODUCTION AND OBJECTIVES X-linked agammaglobulinemia (XLA), the first known primary immunodeficiency, is caused by rare mutations in Bruton's tyrosine kinase (BTK) gene.
Zoha Shaka   +8 more
semanticscholar   +1 more source

Absent B cells, agammaglobulinemia, and hypertrophic cardiomyopathy in Folliculin Interacting Protein 1 deficiency.

open access: yesBlood, 2020
Agammaglobulinemia is the most profound primary antibody deficiency that can occur due to an early termination of B-cell development. We here investigated three novel patients, including the first known adult, from unrelated families with ...
F. Saettini   +33 more
semanticscholar   +1 more source

Sustained correction of B-cell development and function in a murine model of X-linked agammaglobulinemia (XLA) using retroviral-mediated gene transfer [PDF]

open access: yes, 2004
X-linked agammaglobulinemia (XLA) is a human immunodeficiency caused by mutations in Bruton tyrosine kinase (Btk) and characterized by an arrest in early B-cell development, near absence of serum immunoglobulin, and recurrent bacteria infections.
Astrakhan, A.   +9 more
core   +1 more source

Disseminated Metacestode Versteria Species Infection in Woman, Pennsylvania, USA

open access: yesEmerging Infectious Diseases, 2019
A patient in Pennsylvania, USA, with common variable immunodeficiency sought care for fever, cough, and abdominal pain. Imaging revealed lesions involving multiple organs.
Bethany Lehman   +12 more
doaj   +1 more source

Inflammatory Duodenal Polyposis Associated with Primary Immunodeficiency Disease: A Novel Case Report

open access: yesCase Reports in Medicine, 2017
Agammaglobulinemia is a rare form of B-cell primary immunodeficiency disease characterized by reduced levels of IgG, IgA, or IgM and recurrent bacterial infections. Agammaglobulinemia is most commonly associated with diffuse nodular lymphoid hyperplasia.
Irfan Ali Shera   +2 more
doaj   +1 more source

IgM Augments Complement Bactericidal Activity with Serum from a Patient with a Novel CD79a Mutation [PDF]

open access: yes, 2018
Antibody replacement therapy for patients with antibody deficiencies contains only IgG. As a result, concurrent IgM and IgA deficiency present in a large proportion of antibody deficient patients persists.
Burg, M. (Mirjam) van der   +6 more
core   +1 more source

Quality of life in children with primary antibody deficiency. [PDF]

open access: yes, 2014
Primary antibody deficiency disorders (PADs) can have an excellent outlook if diagnosed early and treated appropriately, but require lifelong treatment with immunoglobulin replacement.
Allwood, Z   +8 more
core   +1 more source

Clinic of humoral primary immunodeficiencies in adults. Experience in a tertiary hospital

open access: yesRevista Alergia México, 2016
Background: Primary immunodeficiencies (PID) are characterized by alteration of the components of the immune system. Humoral deficiencies represent 50%.
Julio César Cambray-Gutiérrez   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy